Signaling pathway switch in breast cancer

被引：0

作者：

Arnaud Guille

Max Chaffanet

Daniel Birnbaum

机构：

[1] Aix-Marseille Université,Centre de Recherche en Cancérologie de Marseille, Oncologie Moléculaire, “Equipe labellisée Ligue Contre le Cancer”, UMR1068 Inserm, CNRS UMR7258, Institut Paoli

来源：

Cancer Cell International | / 13卷

关键词：

Next generation sequencing; Breast cancer; Signaling pathways; Cell cycle; Kinases;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Next generation sequencing studies have drawn the general landscape of breast cancers and identified hundreds of new, actual therapeutic targets. Two major signaling pathways seem to be altered in a vast proportion of breast cancers. The PI3 kinase/AKT pathway is activated and the JUN/MAPK pathway is repressed. Via the regulation of the cell cycle this metabolic switch impacts on the balance between self-renewal, proliferation and differentiation of the tumor-initiating cells

引用

共 50 条

[21] The mevalonate pathway in breast cancer biology [J].

Gobel, Andy ;

Riffel, Romy M. ;

Hofbauer, Lorenz C. ;

Rachner, Tilman D. .

CANCER LETTERS, 2022, 542

[22] Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway [J].

Zhu Xiaojue ;

Li Yonghao ;

Xu Guoxin ;

Fu ChangQing .

FEBS OPEN BIO, 2020, 10 (06) :1013-1020

[23] UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway [J].

Lu, Zi-Nan ;

Song, Jia ;

Sun, Tong-Hui ;

Sun, Gang .

CHINESE MEDICAL JOURNAL, 2021, 134 (20) :2465-2474

[24] Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro [J].

Sun, Zhihong ;

Zhou, Cheng ;

Liu, Feng ;

Zhang, Wenchao ;

Chen, Jing ;

Pan, Yanlong ;

Ma, Lianqing ;

Liu, Qimin ;

Du, Yuping ;

Yang, Jinbo ;

Wang, Qin .

ONCOLOGY LETTERS, 2018, 15 (01) :908-916

[25] Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells [J].

Serrano-Lopez, Emilio M. ;

Coronado-Parra, Teresa ;

Marin-Vicente, Consuelo ;

Szallasi, Zoltan ;

Gomez-Abellan, Victoria ;

Jose Lopez-Andreo, Maria ;

Gragera, Marcos ;

Gomez-Fernandez, Juan C. ;

Lopez-Nicolas, Ruben ;

Corbalan-Garcia, Senena .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)

[26] Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer [J].

Asghari, F. ;

Haghnavaz, N. ;

Baradaran, B. ;

Hemmatzadeh, M. ;

Kazemi, T. .

BIOMEDICINE & PHARMACOTHERAPY, 2016, 81 :305-317

[27] Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics [J].

Rie Horii ;

Masaaki Matsuura ;

Shingo Dan ;

Masaru Ushijima ;

Natsue Uehiro ;

Akiko Ogiya ;

Naoko Honma ;

Yoshinori Ito ;

Takuji Iwase ;

Takao Yamori ;

Futoshi Akiyama .

International Journal of Clinical Oncology, 2015, 20 :490-498

[28] The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer [J].

Castaneda, Carlos A. ;

Cortes-Funes, Hernan ;

Gomez, Henry L. ;

Ciruelos, Eva M. .

CANCER AND METASTASIS REVIEWS, 2010, 29 (04) :751-759

[29] HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer [J].

Lin, Ting-, I ;

Tseng, Yi-Ru ;

Dong, Min-Jyun ;

Lin, Chih-Yi ;

Chung, Wei-Ting ;

Liu, Chun-Yu ;

Tsai, Yi-Fang ;

Huang, Chi-Cheng ;

Tseng, Ling-Ming ;

Chao, Ta-Chung ;

Lai, Jiun-, I .

CLINICAL EPIGENETICS, 2025, 17 (01)

[30] The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer [J].

Carlos A. Castaneda ;

Hernán Cortes-Funes ;

Henry L. Gomez ;

Eva M. Ciruelos .

Cancer and Metastasis Reviews, 2010, 29 :751-759

← 1 2 3 4 5 →